The Current Developments Being Made in Cancer Immunotherapy


At the recent Precision Medicine Leaders Summit, the current developments being made in Cancer Immunotherapy were discussed on one of the many roundtables organised during the event. We took the opportunity to interview Alessandra Cesano, M.D., Ph.D. Chief Medical Officer at NanoString Technologies who participated in that discussion, to explore what her perspectives and
hopes are for this burgeoning field.

View PDF